Found: 144
Select item for more details and to access through your institution.
Analysis of Real-world Data on Postremission Therapy for Acute Myeloid Leukemia With Intermediate Risk Cytogenetics in First Complete Remission.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Rapid detection of fungal pathogens in bronchoalveolar lavage samples using panfungal PCR combined with high resolution melting analysis.
- Published in:
- Medical Mycology, 2016, v. 54, n. 7, p. 714, doi. 10.1093/mmy/myw032
- By:
- Publication type:
- Article
Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 615, doi. 10.1002/ajh.27246
- By:
- Publication type:
- Article
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 763, doi. 10.1002/ajh.27229
- By:
- Publication type:
- Article
Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE‐A.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E416, doi. 10.1002/ajh.26692
- By:
- Publication type:
- Article
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph<sup>+</sup> chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. 1215, doi. 10.1002/ajh.26650
- By:
- Publication type:
- Article
Safety and efficacy of self‐administered romiplostim in patients with immune thrombocytopenia: Results of an integrated database of five clinical trials.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. 643, doi. 10.1002/ajh.25776
- By:
- Publication type:
- Article
Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 5, p. 546, doi. 10.1002/ajh.25444
- By:
- Publication type:
- Article
Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. E342, doi. 10.1002/ajh.25232
- By:
- Publication type:
- Article
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. 921, doi. 10.1002/ajh.25125
- By:
- Publication type:
- Article
BCR-ABL1 kinase domain mutational analysis of CD34+ stem/progenitor cells in newly diagnosed CML patients by next-generation sequencing.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 10, p. 1016, doi. 10.1002/ajh.23794
- By:
- Publication type:
- Article
Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 9, p. 790, doi. 10.1002/ajh.23508
- By:
- Publication type:
- Article
Apoptosis in chronic myeloid leukemia cells transiently treated with imatinib or dasatinib is caused by residual BCR-ABL kinase inhibition.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 5, p. 385, doi. 10.1002/ajh.23419
- By:
- Publication type:
- Article
Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 2, p. 211, doi. 10.1002/ajh.22213
- By:
- Publication type:
- Article
Clinical and laboratory features of leukemias at the time of diagnosis: An analysis of 1,004 consecutive patients.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 9, p. 800, doi. 10.1002/ajh.22100
- By:
- Publication type:
- Article
Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilization.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 7, p. 550, doi. 10.1002/ajh.22038
- By:
- Publication type:
- Article
Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials?
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 3, p. 318, doi. 10.1002/ajh.21942
- By:
- Publication type:
- Article
Monitoring of minimal residual disease in acute myeloid leukemia with frequent and rare patient-specific NPM1 mutations.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 12, p. 926, doi. 10.1002/ajh.21879
- By:
- Publication type:
- Article
The assessment of human organic cation transporter 1 ( hOCT1) mRNA expression in patients with chronic myelogenous leukemia is affected by the proportion of different cells types in the analyzed cell population.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 7, p. 525, doi. 10.1002/ajh.21722
- By:
- Publication type:
- Article
Persistent splenomegaly during imatinib therapy and the definition of complete hematological response in chronic myelogenous leukemia.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 5, p. 386, doi. 10.1002/ajh.21689
- By:
- Publication type:
- Article
Comparison of the effect of amphotericin B desoxycholate and amphotericin B colloidal dispersion on renal functions and renal morphology in rats.
- Published in:
- Nephrology, 2005, v. 10, n. 1, p. 57, doi. 10.1111/j.1440-1797.2005.00339.x
- By:
- Publication type:
- Article
Detection of Minimal Residual Disease in Mantle Cell Lymphoma--Establishment of Novel Eight-Color Flow Cytometry Approach.
- Published in:
- Cytometry. Part B, 2015, v. 88, n. 2, p. 92, doi. 10.1002/cyto.b.21210
- By:
- Publication type:
- Article
Prognostic impact of early‐versus‐late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 5, p. 708, doi. 10.1111/ejh.13602
- By:
- Publication type:
- Article
Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin.
- Published in:
- PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0204290
- By:
- Publication type:
- Article
Role of Treatment in the Appearance and Selection of BCR-ABL1 Kinase Domain Mutations.
- Published in:
- Molecular Diagnosis & Therapy, 2012, v. 16, n. 4, p. 251, doi. 10.1007/BF03262214
- By:
- Publication type:
- Article
Analysis of Mutations in the BCR-ABL1 Kinase Domain, Using Direct Sequencing.
- Published in:
- Molecular Diagnosis & Therapy, 2012, v. 16, n. 3, p. 163, doi. 10.1007/BF03262204
- By:
- Publication type:
- Article
A Case of a Novel PML/RARA Short Fusion Transcript with Truncated Transcription Variant 2 of the RARA Gene.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
CEBPA Gene Mutational Status.
- Published in:
- Molecular Diagnosis & Therapy, 2009, v. 13, n. 3, p. 195, doi. 10.1007/BF03256325
- By:
- Publication type:
- Article
Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 6, p. E36, doi. 10.3816/CLM.2009.n.098
- By:
- Publication type:
- Article
Long-Term Outcomes of Autologous Transplantation in Multiple Myeloma: Significant Survival Benefit of Novel Drugs in Post-Transplantation Relapse.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 6, p. 436, doi. 10.3816/CLM.2009.n.086
- By:
- Publication type:
- Article
Value of [18F]Fluorodeoxyglucose Positron Emission Tomography in the Management of Follicular Lymphoma: The End of a Dilemma?
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 5, p. 287
- By:
- Publication type:
- Article
Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Idiopathic Systemic Capillary Leak Syndrome Misdiagnosed and Treated as Polycythemia vera.
- Published in:
- Acta Haematologica, 2005, v. 113, n. 2, p. 150, doi. 10.1159/000083455
- By:
- Publication type:
- Article
Transplantace srdce a následující léčba AL-amyloidózy u 5 pacientů.
- Published in:
- Internal Medicine / Vnitrni Lekarstvi, 2018, v. 64, n. 4, p. 441, doi. 10.36290/vnl.2018.063
- By:
- Publication type:
- Article
Remise „the disease associated/related with immunoglobulin IgG4“ provázeného mnohodetnou lymfadenopatií po léčbě rituximabem a dexametazonem: kazuistika.
- Published in:
- Internal Medicine / Vnitrni Lekarstvi, 2018, v. 64, n. 3, p. 290, doi. 10.36290/vnl.2018.040
- By:
- Publication type:
- Article
Post hoc analysis of the relationship between baseline white blood cell count and survival outcome in a randomized Phase III trial of decitabine in older patients with newly diagnosed acute myeloid leukemia.
- Published in:
- Journal of Blood Medicine, 2015, v. 6, p. 25, doi. 10.2147/JBM.S64067
- By:
- Publication type:
- Article
Diagnosis of Bloom Syndrome in a Patient with Short Stature, Recurrence of Malignant Lymphoma, and Consanguineous Origin.
- Published in:
- Molecular Syndromology, 2020, v. 11, n. 2, p. 73, doi. 10.1159/000507006
- By:
- Publication type:
- Article
IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 10, p. 686, doi. 10.1016/j.clml.2021.05.012
- By:
- Publication type:
- Article
MPN-106: Improved Transfusion Independence Rates for Momelotinib vs Ruxolitinib in Anemic JAKi-Naïve Myelofibrosis Patients are Independent of Baseline Platelet or Transfusion Status.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S353, doi. 10.1016/S2152-2650(21)01817-6
- By:
- Publication type:
- Article
Poster: MPN-106: Improved Transfusion Independence Rates for Momelotinib vs Ruxolitinib in Anemic JAKi-Naïve Myelofibrosis Patients are Independent of Baseline Platelet or Transfusion Status.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S231, doi. 10.1016/S2152-2650(21)01453-1
- By:
- Publication type:
- Article
Characterization of Duvelisib in Patients with Refractory Marginal Zone Lymphoma: Data from the Phase 2 DYNAMO Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S312, doi. 10.1016/j.clml.2019.07.283
- By:
- Publication type:
- Article
Outcome of the Rare Myeloma Subtypes- An Analysis of the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) Data.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e73, doi. 10.1016/j.clml.2017.03.132
- By:
- Publication type:
- Article
Outcome of Third Salvage Autologous Stem Cell Transplantation in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e124, doi. 10.1016/j.clml.2017.03.225
- By:
- Publication type:
- Article
Multiple myeloma associated IgA pemphigus: treatment with bortezomib- and lenalidomid-based regimen.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Multiple Myeloma Associated IgA Pemphigus: Treatment With Bortezomib- and Lenalidomide-Based Regimen.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 6, p. 517, doi. 10.1016/j.clml.2011.06.014
- By:
- Publication type:
- Article
Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia - Czech national study.
- Published in:
- Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2020, v. 164, n. 4, p. 425, doi. 10.5507/bp.2019.046
- By:
- Publication type:
- Article
FDG-PET positive pilomatrixoma -- reconsidering multicentricity in Langerhans cell histiocytosis.
- Published in:
- Nuclear Medicine Review, 2014, v. 17, n. 2, p. 94, doi. 10.5603/NMR.2014.0024
- By:
- Publication type:
- Article
The role of quantitative Tc-99m-MIBI gated SPECT/F-18-FDG PET imaging in the monitoring of intracoronary bone marrow cell transplantation.
- Published in:
- Nuclear Medicine Review, 2006, v. 9, n. 1, p. 60
- By:
- Publication type:
- Article
Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2016, v. 108, n. 7, p. 1, doi. 10.1093/jnci/djw003
- By:
- Publication type:
- Article